Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors

Clinical and Experimental Metastasis

Volumn 15, Issue 4, 1997, Pages 440-446

  Go, Yoshinori ^a   Chintala, Shravan K ^a   Mohanam, Sanjeeva ^a   Gokaslan, Ziya ^a   Venkaiah, Boyapati ^a   Bjerkvig, Rolf ^b   Oka, Kazunari ^c   Nicolson, Garth L ^d   Sawaya, Raymond ^a   Rao, Jasti S ^a,e  

^a UNIVERSITY OF TEXAS   (United States)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c FUKUOKA UNIVERSITY   (Japan)

^d Institute for Molecular Medicine   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Activators; Antisense; Brain; Glioblastoma; lacZ; Plasminogen; Tumor; uPAR

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COMPLEMENTARY DNA; UROKINASE RECEPTOR;

ARTICLE; CARCINOGENICITY; CELL INVASION; CONTROLLED STUDY; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; TUMOR CELL LINE;

ANIMALS; ANTISENSE ELEMENTS (GENETICS); BETA-GALACTOSIDASE; BRAIN; CARCINOGENICITY TESTS; COCULTURE TECHNIQUES; FEMALE; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; STAINING AND LABELING; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 8544254674     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018410523635     Document Type: Article

References (22)

1. Vassalli JD, Sappino AP and Belin D, 1991, The plasminogen activator/plasmin system. J Clin Invest, 88, 1067-72.
2. Mackay AR, Corbit RH, Hartzler JL and Thorgeirsson UP, 1990, Basement membrane type IV collagen degradation: Evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res, 50, 5997-6001.
3. Nielsen LS, Kellerman GM, Behrendt N, et al. 1988, 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator: Identification in human tumor cell lines and partial purification. J Biol Chem, 263, 2358-63.
4. Stetler-Stevenson WG, Liotta LA and Kleiner DE, 1993, Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J, 7, 1434-41.
5. Pollanen J, Stephens RW and Vaheri A, 1991, Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res, 57, 273-328.
6. Yamamoto M, Sawaya R, Mohanam S, et al. 1994, Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res, 54, 5016-20.
7. Mohanam S, Sawaya R, McCutcheon I, et al. 1993, Modulation of in vitro invasion of human glioblastoma cells by urokinase type plasminogen activator receptor antibody. Cancer Res, 53, 4143-47.
8. Wilhelm O, Weidle U and Hohl S, 1994, Recombinant soluble urokinase receptor as a scavenger for urokinase type plasminogen activator: Inhibition of proliferation and invasion of human ovarian cells. FEBS Lett, 337, 131-4.
9. Crowley CW, Cohen RL, Lucas BK, et al. 1993, Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci USA, 90, 5021-52.
10. Pedersen PH, Marienhagen K, Mork S and Bjerkvig R, 1993, Migratory pattern of fetal rat brain cells and human glioma cells in adult rat brain. Cancer Res, 53, 5158-65.
11. Kook YH, Adamski J, Zelent A, et al. 1994, The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy. EMBO J, 13, 3983-91.
12. Roldan AL, Cubellis MV, Masucci, et al. 1990, Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin-dependent proteolysis, EMBO J, 9, 467-74.
13. Wang H, Skibber J and Boyd D, 1994, Transcriptional activation of the urokinase receptor gene in invasive colon cancer. Int J Cancer, 58, 650-7.
14. Mohanam S, Chintala SK, Go Y, Bhattacharya A, et al. 1997, In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene, in press.
15. Go Y, Chintala SK, Oka K, et al. 1996, Invasive pattern of lac-Z transfected human glioblastoma cells in nude mice brain. Cancer Lett, 110, 225-31.
16. Bjerkvig R, Laerum OD and Mella O, 1986, Glioma cell interactions with fetal rat brain aggregates in vitro, and with brain tissue in vivo. Cancer Res, 46, 4071-9.
17. Engebraaten O, Bjerkvig R, Lund-Johnsen M, et al. 1990, Interaction between human brain tumor biopsies and fetal rat brain tissue in vitro. Acta Neuropathol, 18, 130-40.
18. Stahl A and Mueller BM, 1994, Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res, 54, 3066-71.
19. Danø K, Andreasen PA and Grondahl-Hansen J, 1985, Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res, 44, 139-266.
20. Kariko K, Kuo A and Boyd D, 1993, Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line. Cancer Res, 53, 3109-17.
21. Ossowski L, Clunie G, Masucci MM and Blasi F, 1991, In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. J Cell Biol, 115, 1107-12.
22. Quattrone A, Fibbi G and Anichini E, 1995, Antimessenger oligonucleotide for urokinase receptor gene inhibits invasivity of transformed human fibroblasts. Anticancer Drug Design, 10, 97-102.